Is it time for medicine-based evidence?

JAMA

Volumn 307, Issue 15, 2012, Pages 1641-1643

  Concato, John ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ABDOMINAL AORTA ANEURYSM; AGE DISTRIBUTION; ANALYTIC METHOD; CANCER CHEMOTHERAPY; CLINICAL FEATURE; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED RADIOTHERAPY; EDITORIAL; EFFECT SIZE; EMERGENCY HEALTH SERVICE; EVIDENCE BASED MEDICINE; HUMAN; LUNG CANCER; METHODOLOGY; NEPHRECTOMY; OBSERVATIONAL STUDY; PATIENT CARE; PRIORITY JOURNAL; PROPENSITY SCORE; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; STUDY DESIGN; TREATMENT OUTCOME;

EID: 84859880167     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.482     Document Type: Editorial

References (20)

1. Galvagno Jr SM, Haut ER, Zafar SN, et al. Association between helicopter vs ground emergency medical services and survival for adults with major trauma. JAMA. 2012;307(15):1602-1610.
2. Jackson RS, Chang DC, Freischlag JA. Comparison of long-term survival after open vs endovascular repair of intact abdominal aortic aneurysm among Medicare beneficiaries. JAMA. 2012;307(15):1621-1628.
3. Sheets NC, Goldin GH, Meyer A-M, et al. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy with morbidity and disease control in localized prostate cancer. JAMA. 2012;307(15):1611-1620.
4. Tan H-J, Norton EC, Ye Z, Hafez KS, Gore JL, Miller DC. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA. 2012;307(15):1629-1635.
5. Zhu J, Sharma DB, Gray SW, Chen AB, Weeks JC, Schrag D. Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA. 2012;307(15):1593-1601.
6. Rawlins M. De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet. 2008;372(9656):2152-2161.
7. Concato J, Lawler EV, Lew RA, Gaziano JM, Aslan M, Huang GD. Observational methods in comparative effectiveness research. Am J Med. 2010;123 (12)(suppl 1):e16-e23.
8. Feinstein AR. Multivariable Analysis: An Introduction. New Haven, CT: Yale University Press; 1996.
9. Truett J, Cornfield J, Kannel W. A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis. 1967;20(7):511-524.
10. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999;150(4):327-333. (Pubitemid 29383480)
11. Klungel OH, Martens EP, Psaty BM, et al. Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol. 2004; 57(12):1223-1231. (Pubitemid 40023141)
12. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA. 2007;297(3):278-285. (Pubitemid 46143305)
13. Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH. Instrumental variables: application and limitations. Epidemiology. 2006;17(3):260-267.
14. Shah BR, Laupacis A, Hux JE, Austin PC. Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol. 2005;58(6):550-559. (Pubitemid 40692720)
15. Austin PC, Mamdani MM, Stukel TA, Anderson GM, Tu JV. The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med. 2005;24(10):1563-1578. (Pubitemid 40716354)
16. Concato J. Overview of research design in epidemiology. J Law Policy. 2004; 12:489-507.
17. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25): 1887-1892. (Pubitemid 30419054)
18. Chao HH, Mayer T, Concato J, Rose MG, Uchio E, Kelly WK. Prostate cancer, comorbidity, and participation in randomized controlled trials of therapy. J Investig Med. 2010;58(3):566-568.
19. Concato J, Horwitz RI. Beyond randomised versus observational studies. Lancet. 2004;363(9422):1660-1661. (Pubitemid 38670319)
20. Vandenbroucke JP. The HRT controversy: observational studies and RCTs fall in line. Lancet. 2009;373(9671):1233-1235.